We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Bacterial Isolates Identified by Colorimetric Cards

By LabMedica International staff writers
Posted on 21 Dec 2010
A rapid and accurate bacterial identification system for Staphylococci species has been validated in a clinical setting. More...


A procedure that uses colorimetric identification card and automation has been compared with molecular methods to identify bacteria from patient's samples that were isolated and recovered during routine testing.

Scientists from the Medical School at the University of Athens (Greece), isolated 147 clinical isolates: 52 Staphylococcus aureus, 50 Staphylococcus epidermidis, and 45 other coagulase-negative Staphylococci (CoNS). These isolates were recovered from various clinical samples including blood, wound, catheter tips, respiratory, and urine during routine testing, and for the majority of them, their isolation was considered clinically significant. The bacteria were first identified by molecular methodology and then comparatively tested by Vitek 2, colorimetric identification card, and Phoenix using the novel 0.25 McFarland and the standard 0.50 McFarland inoculum protocols.

All S. aureus isolates were accurately identified. Vitek 2 (bioMérieux, Marcy l'Etoile, France) identified correctly all S. epidermidis and 93.3% of the other CoNS, whereas the respective rates were 86% and 82.2% for Phoenix's standard and 92% and 82.2% for the novel protocol. The PMIC/ID-53 panel for Gram-positive cocci and software version V5.10A/V4.23D were used for identification by Phoenix system (Becton Dickinson Diagnostic Systems, Franklin Lane, NJ, USA).

The authors concluded that both systems provide excellent identification of S. aureus, but Vitek 2 recognizes CoNS species more accurately than Phoenix. The 0.25 McFarland protocol does not improve system performance. However, they also note specificity of testing is an important parameter and needs to be determined also. It is imperative that such evaluation studies use reference phenotypic or molecular identification methods for comparison. The study was published online on November 19, 2010 in Diagnostic Microbiology and Infectious Disease.

Related Links:
University of Athens
bioMérieux
Becton Dickinson Diagnostic Systems



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.